Neurogenic Drugs and compounds to treat CNS diseases and Disorders

Central Nervous System Agents in Medicinal Chemistry

Volumn 11, Issue 1, 2011, Pages 35-37

  Taupin, Philippe ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Alzheimer disease; Depression; Drug; Hippocampus; Neurogenesis; Neurogenic; Pharmacology; Regeneration; Therapy

Indexed keywords

1 (2 CHLORO 7,8 DIMETHYL QUINOLIN 3 YLMETHYL) 1 (2 METHOXY ETHYL) 3 (2 METHOXY PHENYL) UREA; 4 (3 CYANO 5,7 DIMETHYL QUINOLIN 2 YL) [1,4]DIAZEPANE 1 CARBOTHIOIC ACID (2 METHOXY PHENYL) AMIDE; 4 (3 CYANO 6 ETHOXY QUINOLIN 2 YL) [L,4]DIAZEPANE 1 CARBOXYLIC ACID (2 FLUORO PHENYL) AMIDE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; APIGENIN; CENTRAL NERVOUS SYSTEM AGENTS; N (4 ACETYL 1 PIPERAZINYL) 4 FLUOROBENZAMIDE; PIRACETAM; SGS 111; UNCLASSIFIED DRUG; DRUG;

ADULT; ALZHEIMER DISEASE; ARTICLE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; DENTATE GYRUS; DEPRESSION; DRUG EFFICACY; DRUG TARGETING; EPILEPSY; HIPPOCAMPAL MOSSY FIBER; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; LEARNING; MAZE TEST; MEMORY; MULTIPLE SCLEROSIS; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; RECOGNITION; SPINAL CORD INJURY; STEM CELL; SUBVENTRICULAR ZONE; TRAUMATIC BRAIN INJURY; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASES; CHEMICAL STRUCTURE; CYTOLOGY; DRUG EFFECTS; NEURAL STEM CELL; PHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; HIPPOCAMPUS; HUMANS; MOLECULAR STRUCTURE; NEURAL STEM CELLS; NEUROGENESIS; PHARMACEUTICAL PREPARATIONS;

EID: 79953010311     PISSN: 18715249     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152411794961103     Document Type: Article

References (24)

1. st ed. World Health Organization. (5 April 2007).
2. Taupin, P.; Gage, F.H. Adult neurogenesis and neural stem cells of the central nervous system in mammals. J. Neurosci. Res., 2002, 69, 745-749.
3. Taupin, P. Adult neural stem cells, neurogenic niches and cellular therapy. Stem Cell Rev., 2006, 2, 213-220.
4. Kempermann, G.; Kuhn, H.G.; Gage, F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature, 1997, 386, 493-495.
5. Shors, T.J.; Miesegaes, G.; Beylin, A.; Zhao, M.; Rydel, T.; Gould, E. Neurogenesis in the adult is involved in the formation of trace memories. Nature, 2001, 410, 372-376.
6. Erratum in: Nature, 2001, 414, 938.
7. Jin, K.; Xie, L.; Mao, X.O.; Greenberg, D.A. Alzheimer's disease drugs promote neurogenesis. Brain Res., 2006, 1085, 183-188.
8. Perera, T.D.; Coplan, J.D.; Lisanby, S.H.; Lipira, C.M.; Arif, M.; Carpio, C.; Spitzer, G.; Santarelli, L.; Scharf, B.; Hen, R.; Rosoklija, G.; Sackeim, H.A.; Dwork, A.J. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J. Neurosci., 2007, 27, 4894-4901.
9. Parent, J.M.; Yu, T.W.; Leibowitz, R.T.; Geschwind, D.H.; Sloviter, R.S.; Lowenstein, D.H. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J. Neurosci., 1997, 17, 3727-3738.
10. Taupin, P. Adult neurogenesis, neural stem cells and Alzheimer's disease: Developments, limitations, problems and promises. Curr. Alzheimer Res., 2009, 6, 461-470.
11. Santarelli, L.; Saxe, M.; Gross, C.; Surget, A.; Battaglia, F.; Dulawa, S.; Weisstaub, N.; Lee, J.; Duman, R.; Arancio, O.; Belzung, C.; Hen, R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 2003, 310, 805-809.
12. Taupin, P. Neurogenesis and the Effects of Antidepressants. Drug Target Insights, 2006, 1, 13-17.
13. Taupin, P. Adult neurogenesis pharmacology in neurological diseases and disorders. Exp. Rev. Neurother., 2008, 8, 311-320.
14. Braitenberg, V.; Schüz, A. Some anatomical comments on the hippocampus. In Seifert W, Ed. Neurobiology of the hippocampus. Academic Press, 1983, pp. 21-37.
15. Toni, N.; Teng, E.M.; Bushong, E.A.; Aimone, J.B.; Zhao, C.; Consiglio, A.; van Praag, H.; Martone, M.E.; Ellisman, M.H.; Gage, F.H. Synapse formation on neurons born in the adult hippocampus. Nat. Neurosci., 2007, 10, 727-734.
16. Taupin, P. Characterization and isolation of synapses of newly generated neuronal cells of the adult hippocampus at early stages of neurogenesis. J. Neurodegener. Regen., 2009, 2, 9-17.
17. Taupin, P. Nootropic agents stimulate neurogenesis. Expert Opin. Ther. Pat., 2009, 19, 727-730.
18. Taupin, P. Apigenin and related compounds stimulate adult neurogenesis. Expert Opin. Ther. Pat., 2009, 19, 523-527.
19. Taupin, P. Fourteen compounds and their derivatives for the treatment of diseases and injuries characterized by reduced neurogenesis and neurodegeneration. Expert Opin. Ther. Pat., 2009, 19, 541-547.
20. Taupin, P. Neurogenic drugs and compounds. Recent Pat. CNS Drug Discov., 2010, 5, 253-257.
21. Lucassen, P.J.; Stumpel, M.W.; Wang, Q.; Aronica, E. Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients. Neuropharmacology, 2010, 58, 940-949.
22. Taupin, P. BrdU Immunohistochemistry for Studying Adult Neurogenesis: Paradigms, pitfalls, limitations, and validation. Brain Res. Rev., 2007, 53, 198-214.
23. Brazel, C.Y.; Limke, T.L.; Osborne, J.K.; Miura, T.; Cai, J.; Pevny, L.; Rao, M.S. Sox2 expression defines a heterogeneous population of neurosphere-forming cells in the adult murine brain. Aging Cell, 2005, 4, 197-207.
24. Taupin, P. Adult neurogenesis and neural stem cells as a model for the discovery and development of novel drugs. Expert Opin. Drug Discov., 2010, 5, 921-925.